Literature DB >> 8111940

Is hypoxic pulmonary vasoconstriction important during single lung ventilation in the lateral decubitus position?

M Friedlander1, A Sandler, B Kavanagh, T Winton, J Benumof.   

Abstract

Hypoxic pulmonary vasoconstriction (HPV) has not been demonstrated in human single lung anaesthesia in the lateral decubitus position (LDP). The purpose of this study was to determine whether (1) HPV occurs in the non-dependent, non-ventilated lung, and (2) if the infusion of sodium nitroprusside (SNP) inhibits HPV. During intravenous anaesthesia the tracheas of seven patients were intubated with double lumen endotracheal tubes. Standard monitors plus radial and pulmonary arterial catheters were placed. Patients were positioned in the LDP and haemodynamic and gas exchange data were recorded for each of three stages; I: two-lung ventilation, II: single, dependent lung ventilation (1 LV) and III: 1LV with infusion of SNP. In stage II the PaO2 decreased from 531 +/- 42 mmHg to 285 +/- 42 mmHg (P < 0.05) and Qs/Qt increased from 12.3 +/- 2.7 to 29.0 +/- 6.3% (P < 0.05). With SNP infusion there was a 30% increase in cardiac index (CI) (P < 0.05). The SNP infusion was not associated with changes in Qs/Qt or PaO2. This model demonstrates changes in Qs/Qt and PaO2 associated with single-lung ventilation in ASA I and II patients in the LDP but we were unable to demonstrate inhibition of HPV by SNP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8111940     DOI: 10.1007/BF03009657

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  35 in total

1.  A hypoxic pulmonary vasoconstrictor response in dogs during and after infusion of sodium nitroprusside.

Authors:  A B Hill; M K Sykes; A Reyes
Journal:  Anesthesiology       Date:  1979-06       Impact factor: 7.892

2.  Time course of pulmonary vascular response to hypoxia in dogs.

Authors:  A B Malik; B S Kidd
Journal:  Am J Physiol       Date:  1973-01

3.  General anesthetics and regional hypoxic pulmonary vasoconstriction.

Authors:  J Mathers; J L Benumof; E A Wahrenbrock
Journal:  Anesthesiology       Date:  1977-02       Impact factor: 7.892

4.  Nonsustained pulmonary vasoconstriction during acute hypoxia in anesthetized dogs.

Authors:  A Tucker; J T Reeves
Journal:  Am J Physiol       Date:  1975-03

5.  Gestational changes in pulmonary vascular responses in fetal lambs in utero.

Authors:  A B Lewis; M A Heymann; A M Rudolph
Journal:  Circ Res       Date:  1976-10       Impact factor: 17.367

Review 6.  [Cardiopulmonary adaptation to acute hypoxia (author's transl)].

Authors:  N Konietzko; H Matthys
Journal:  Klin Wochenschr       Date:  1976-12-15

7.  Hypoxic pulmonary vasoconstriction in the human lung: the effect of prolonged unilateral hypoxic challenge during anaesthesia.

Authors:  A J Carlsson; L Bindslev; J Santesson; I Gottlieb; G Hedenstierna
Journal:  Acta Anaesthesiol Scand       Date:  1985-04       Impact factor: 2.105

8.  Comparison of the effects of dobutamine, dopamine, and isoproterenol on hypoxic pulmonary vasoconstriction in the pig.

Authors:  W R Furman; W R Summer; T P Kennedy; J T Sylvester
Journal:  Crit Care Med       Date:  1982-06       Impact factor: 7.598

9.  Depression of hypoxic pulmonary vasoconstriction in the dog by dopamine and isoprenaline.

Authors:  J L Marin; C Orchard; M K Chakrabarti; M K Sykes
Journal:  Br J Anaesth       Date:  1979-04       Impact factor: 9.166

10.  Depression of hypoxic pulmonary vasoconstriction by sodium nitroprusside and nitroglycerine.

Authors:  M D'Oliveira; M K Sykes; M K Chakrabarti; C Orchard; J Keslin
Journal:  Br J Anaesth       Date:  1981-01       Impact factor: 9.166

View more
  1 in total

1.  Effect of desflurane-remifentanil vs. Propofol-remifentanil anesthesia on arterial oxygenation during one-lung ventilation for thoracoscopic surgery: a prospective randomized trial.

Authors:  Youn Joung Cho; Tae Kyong Kim; Deok Man Hong; Jeong-Hwa Seo; Jae-Hyon Bahk; Yunseok Jeon
Journal:  BMC Anesthesiol       Date:  2017-01-18       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.